RPL10 and T-cell acute lymphoblastic leukemia: However, the translation of BCL-2 could be specifically compensated by IRES activation, as researchers have reported that IRES-dependent BCL-2 contributed to the malignant element of RPL10 R98S mutation in pediatric T-cell acute lymphoblastic leukemia [39].